ciprofloxacin has been researched along with thromboxane a2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beil, WJ; Georgopoulos, A; Graninger, W; Griesmacher, A; Hlousek, M; Robibaro, B; Schaumann, R; Vorbach, H; Weigel, G | 1 |
| Armbruster, C; Georgopoulos, A; Graninger, W; Griesmacher, A; Hlousek, M; Reiter, M; Robibaro, B; Vorbach, H; Weigel, G | 1 |
2 other study(ies) available for ciprofloxacin and thromboxane a2
| Article | Year |
|---|---|
Endothelial cell compatibility of fluoroquinolone solutions for intravenous use.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Triphosphate; Anti-Infective Agents; Cell Survival; Cells, Cultured; Ciprofloxacin; Endothelium, Vascular; Epoprostenol; Firefly Luciferin; Fleroxacin; Humans; Injections, Intravenous; Luciferases; Ofloxacin; Radioimmunoassay; Thromboxane A2; Umbilical Veins | 1997 |
Endothelial purine content. An alternative model for testing antibiotic solutions for intravenous use.
Topics: Adenosine Triphosphate; Anti-Infective Agents; Cell Survival; Cells, Cultured; Ciprofloxacin; Drug Evaluation, Preclinical; Endothelium, Vascular; Epoprostenol; Fleroxacin; Humans; Ofloxacin; Solutions; Thromboxane A2; Umbilical Veins | 1998 |